Researchers found that INMT levels were lower in lung, meningioma, and prostate cancers (Kopantzev et al., 2008; Larkin et al., 2012; Schulten et al., 2016); however, the role of INMT in cancer is unclear. This evidence concerns the gene INMT and prostate cancer.